Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01451
Species: Homo sapiens
Position : chr5:1320000-1322000
Year: 2021
Title: Enhancer release and retargeting activates disease-susceptibility genes
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  34040254
MONDO:
Tissue: Embryonic Kidney
Tissue Ontology ID: UBERON:0002113
Cell Source: 293T
CVCL ID: CVCL_0063
Cell Type: embryonic kidney cell
Cell Ontology ID: CL:0002139
Experiment Type: Enhancer activity assay, Functional perturbation assay, TF binding assay, Chromatin interaction assay
High Throughput Method: ChIP-seq, Hi-C, ChIA-PET, RNA-seq, WGS
Low Throughput Method: CRISPR Knockout, RT-RT-qPCR, 4C-seq, ChIP-RT-qPCR, Sanger Sequencing
About Target Gene
Target gene : TERT
About TF
TF name : CTCF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CTCF Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
CTCF TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg38) 2 found
Enhancer ID Position Tissue Cell Disease
E_01666 chr5:1230131-1337133 Liver hepatocellular carcinoma cell hepatocellular carcinoma
E_01319 chr5:1320000-1322000 Embryonic Kidney embryonic kidney cell --
Expression of Target Genes for the Enhancer